2883 related articles for article (PubMed ID: 15351765)
1. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia.
González-Blanch C; Perez-Iglesias R; Pardo-García G; Rodríguez-Sánchez JM; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2010 Jun; 40(6):935-44. PubMed ID: 19751542
[TBL] [Abstract][Full Text] [Related]
4. Durability and mechanism of effects of cognitive enhancement therapy.
Hogarty GE; Greenwald DP; Eack SM
Psychiatr Serv; 2006 Dec; 57(12):1751-7. PubMed ID: 17158490
[TBL] [Abstract][Full Text] [Related]
5. Social cognitive markers of short-term clinical outcome in first-episode psychosis.
Montreuil T; Bodnar M; Bertrand MC; Malla AK; Joober R; Lepage M
Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):105-14. PubMed ID: 20643633
[TBL] [Abstract][Full Text] [Related]
6. Identifying mechanisms of treatment effects and recovery in rehabilitation of schizophrenia: longitudinal analytic methods.
Peer JE; Kupper Z; Long JD; Brekke JS; Spaulding WD
Clin Psychol Rev; 2007 Jul; 27(6):696-714. PubMed ID: 17343964
[TBL] [Abstract][Full Text] [Related]
7. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.
Eack SM; Hogarty GE; Cho RY; Prasad KM; Greenwald DP; Hogarty SS; Keshavan MS
Arch Gen Psychiatry; 2010 Jul; 67(7):674-82. PubMed ID: 20439824
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based psychotherapy for schizophrenia.
Dickerson FB; Lehman AF
J Nerv Ment Dis; 2006 Jan; 194(1):3-9. PubMed ID: 16462548
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
[TBL] [Abstract][Full Text] [Related]
11. Deficits of social-cognitive and social-perceptual aspects of theory of mind in remitted patients with schizophrenia: effect of residual symptoms.
Bora E; Gökçen S; Kayahan B; Veznedaroglu B
J Nerv Ment Dis; 2008 Feb; 196(2):95-9. PubMed ID: 18277216
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study.
Girón M; Fernández-Yañez A; Mañá-Alvarenga S; Molina-Habas A; Nolasco A; Gómez-Beneyto M
Psychol Med; 2010 Jan; 40(1):73-84. PubMed ID: 19490746
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
15. Cognitive training for divergent thinking in schizophrenia: a pilot study.
Nemoto T; Yamazawa R; Kobayashi H; Fujita N; Chino B; Fujii C; Kashima H; Rassovsky Y; Green MF; Mizuno M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1533-6. PubMed ID: 19733608
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided neurocognitive remediation as an enhancing strategy for schizophrenia rehabilitation.
Cavallaro R; Anselmetti S; Poletti S; Bechi M; Ermoli E; Cocchi F; Stratta P; Vita A; Rossi A; Smeraldi E
Psychiatry Res; 2009 Oct; 169(3):191-6. PubMed ID: 19740550
[TBL] [Abstract][Full Text] [Related]
17. Theory of mind performance in schizophrenia: diagnostic, symptom, and neuropsychological correlates.
Greig TC; Bryson GJ; Bell MD
J Nerv Ment Dis; 2004 Jan; 192(1):12-8. PubMed ID: 14718771
[TBL] [Abstract][Full Text] [Related]
18. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation.
Vauth R; Corrigan PW; Clauss M; Dietl M; Dreher-Rudolph M; Stieglitz RD; Vater R
Schizophr Bull; 2005 Jan; 31(1):55-66. PubMed ID: 15888425
[TBL] [Abstract][Full Text] [Related]
19. Schizoaffective disorder: a form of schizophrenia or affective disorder?
Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
[TBL] [Abstract][Full Text] [Related]
20. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.
Gehring K; Sitskoorn MM; Gundy CM; Sikkes SA; Klein M; Postma TJ; van den Bent MJ; Beute GN; Enting RH; Kappelle AC; Boogerd W; Veninga T; Twijnstra A; Boerman DH; Taphoorn MJ; Aaronson NK
J Clin Oncol; 2009 Aug; 27(22):3712-22. PubMed ID: 19470928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
